Hatch, S., Swift, L., Caporali, S., Carter, R., Hill, E., Macgregor, T., . . . Sharma, R. (2014). XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection.
Čikaški stil citiranja (17. izdanje)Hatch, S., et al. XPF Protein Levels Determine Sensitivity of Malignant Melanoma Cells to Oxaliplatin Chemotherapy: Suitability as a Biomarker for Patient Selection. 2014.
MLA način citiranja (9. izdanje)Hatch, S., et al. XPF Protein Levels Determine Sensitivity of Malignant Melanoma Cells to Oxaliplatin Chemotherapy: Suitability as a Biomarker for Patient Selection. 2014.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.